Bisphosphonates in Langerhans Cell Histiocytosis: An International Retrospective Case Series

BACKGROUND: Bone is the most common organ of involvement in patients with Langerhans cell histiocytosis (LCH), which is often painful and associated with significant morbidity from pathological fractures. Current first-line treatments include chemotherapy and steroids that are effective but often as...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Mediterr J Hematol Infect Dis
Egile Nagusiak: Chellapandian, Deepak, Makras, Polyzois, Kaltsas, Gregory, van den Bos, Cor, Naccache, Lamia, Rampal, Raajit, Carret, Anne-Sophie, Weitzman, Sheila, Egeler, R. Maarten, Abla, Oussama
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Università Cattolica del Sacro Cuore 2016
Gaiak:
Original Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4928520/
https://ncbi.nlm.nih.gov/pubmed/27413525
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4084/MJHID.2016.033
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak